Crystal Research continued its coverage of Authentidate Holding Corp. (ADAT-NASDAQ) with the publication of a 16-page Quarterly Update covering the second quarter FY 2012, available here.

After the close of business today, we released a new report on Authentidate Holding Corp. (ADAT-NASDAQ). We first initiated coverage on Authentidate in March 2009 and have watched the company expand greatly since then. Its flagship product is Inscrybe^® Healthcare, which provides a means for healthcare organizations and other enterprises to increase revenues, improve productivity, enhance patient care, and reduce costs by eliminating paper and manual work steps while enhancing regulatory compliance. During the past year, Authentidate has announced 11 new projects for Inscrybe^® Healthcare, which include sales to home medical equipment companies, home healthcare service agencies, and respiratory products and service institutions.

Several companies within our Research Library this week reported financial results, including Pro-Pharmaceuticals, Inc. (PRWP-OTC), Authentidate Holding Corp. (ADAT-NASDAQ), Antares Pharma, Inc. (AIS-NYSE Amex), and Bioniche Life Sciences Inc. (BNC-TSX).